Order Drugs Now

TEL: 1 866 893 0369
FAX: 1 866 402 4033

Medical News

Subscribe to Newsletter

To get info on the latest products, specials and pharmacy news, please enter your e-mail address:


August 10th, 2009
Study Proves That Ovarian Cancer Patients Can Maintain Fertility

A new study has proven that it is possible to preserve the fertility of a young woman diagnosed with early stage ovarian cancer, without compromising her survival; the solution is to save the woman’s uterus or ovary.

August 10th, 2009
FDA Commissioner Declares Enforcement Protocol Regarding Public Health Safety

Margaret A. Hamburg M.D., commissioner of the US FDA recently announced her obligation to “prevent harm to the American people” through immediate, dynamic, potent administration of FDA laws and rules.

August 10th, 2009
US FDA Communicates Melamine Testing Recommendations

The US FDA recently issued a recommendation advising that certain pharmaceutical components used in the production or composition of drug products should be tested for melamine.

August 7th, 2009
FDA Warns Consumers of Body Building Products Promoted as Dietary Supplements

The US FDA has advised healthcare practitioners and consumers of current safety information with regard to body building and increase muscle mass products, these products are commonly described as a substitute for anabolic steroids (used to increase muscle mass and strength), available both online and in retail establishments.

August 7th, 2009
Steam Dietary Supplement Pulled From Pharmacy Shelves

The FDA’s laboratory analysis discovered sulfoaildenafil, an analog of sildenafil. Sildenafil is a key ingredient in the FDA-approved drug for erectile dysfunction, which makes Steam an unsanctioned drug.

August 7th, 2009
Baxter Completes CELVAPAN A/H1N1 Pandemic Vaccine

Baxter International has recently announced that they have finished the production of their first commerical batches of CELVAPAN A/H1N1 pandemic vaccine. Currently, Baxter is discussing distribution options with national health authorities, so long as they receive appropriate permission. Baxter implemented their proprietary Vero cell production technology when developing CELVAPAN.

August 7th, 2009
FDA Demands TNF Blockers to Include Cancer Warnings

The US FDA requires TNF blockers to include firm detailed warnings in the prescribing information. The warnings, which also involves an up to date box warning, spotlights the increase chance of cancer in children and adolescents who first obtain the drug to treat juvenile rheumatoid arthritis, inflammatory bowel disease, Crohn's disease and other inflammatory diseases.

August 7th, 2009
Leading Cause of Child Poisonings: Medication

A recent Government report states that the foremost source of poisonings among American children can be located in the household medicine cabinet.

August 7th, 2009
FDA Warns: Clarcon Skin Products Present Health Threats

The US FDA cautions consumers of the harmful effects Clarcon skin products are having on the skin. They urge consumers to cease all usage of Clarcon Biological Chemistry Laboratory skin sanitizer or protectants, because of hazardous bacteria.

August 7th, 2009
Insmed Maintains Limited IPLEX Supply for Existing Patients

Biopharmaceutical company Insmed Inc. has publicized that effective immediately, they will halt new patient distribution of Iplex. They feel it is in the existing patients best interest to maintain supplies at this time for their treatment only. As a result, at this time, Insmed will not instigate further clinical trials of Iplex.


Search for Medication or Types of Conditions



: 0
Total: $0.00

view my cart check out credit cards

Find out how much you can save now!

download order form


Medicine Shoppe Pharmacy
148 #9 31205 Maclure Road
Abbotsford BC, Canada

Ph: 1-866-893-0369
Fax: 1-800-878-7930

Licence J30
Manager: S. Maan


TEL: 1 (866) 893-0369
FAX: 1 (800) 878-7930